Trulicity 1.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8N6A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,518
Award facts
- Contract value 100% obligated
- $11,518.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,518.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen injectors on January 15, 2026, with completion scheduled for January 16, 2026. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999.999 billion through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to military healthcare programs globally.
This delivery order supports the Defense Health Agency and broader military healthcare systems by supplying Trulicity, a diabetes medication, through AmerisourceBergen's established pharmaceutical distribution capabilities. The transaction exemplifies the routine execution of task orders under the DLA's master pharmaceutical contract vehicle, whereby the contractor demonstrates its ability to fulfill critical medical supply requirements on a competitive, firm fixed-price basis. AmerisourceBergen's parent company Cencora holds significant federal contracts across multiple agencies including the Department of Veterans Affairs, leveraging its position as a major pharmaceutical distributor to support federal medical procurement needs.
Quick answers
Who was awarded contract SPE2DR26F8N6A?
SPE2DR26F8N6A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F8N6A worth?
The government has obligated $11,518 on SPE2DR26F8N6A.
Is contract SPE2DR26F8N6A an order under another contract?
Yes. SPE2DR26F8N6A is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N6A competed?
The extent of competition for SPE2DR26F8N6A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award